Assessing the Within‐Trial Treatment Integrity of Discrete‐Trial Teaching Programs Using Sequential Analysis

Discrete‐trial teaching is a strategy frequently used to teach functional skills to individuals with developmental and intellectual disabilities. Research has shown that the within‐trial components of the procedure should be administered with ≥90% treatment integrity to facilitate optimal learning....

Full description

Saved in:
Bibliographic Details
Published in:Behavioral interventions Vol. 32; no. 1; pp. 54 - 69
Main Authors: Brand, Denys, Mudford, Oliver C., Arnold‐Saritepe, Angela, Elliffe, Douglas
Format: Journal Article
Language:English
Published: Chichester Wiley Subscription Services, Inc 01-02-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Discrete‐trial teaching is a strategy frequently used to teach functional skills to individuals with developmental and intellectual disabilities. Research has shown that the within‐trial components of the procedure should be administered with ≥90% treatment integrity to facilitate optimal learning. Usually within‐trial treatment integrity is measured using whole‐session methods such as percentage of trials correctly administered. This study demonstrated one‐step Markov transition matrices as a method of assessing within‐trial treatment integrity. All components of discrete trials were coded and time‐stamped from video recordings of therapist–learner dyads in their typical setting (home or school). Several types of within‐trial treatment integrity errors were identified using the Markov transition matrices, error sequences that could not be identified using a percentage correct analysis. Better identification of errors has the potential both to enhance treatment integrity and to gain efficiency by targeted retraining of therapists. Copyright © 2016 John Wiley & Sons, Ltd.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1072-0847
1099-078X
DOI:10.1002/bin.1455